Search Results

There are 14459 results for: content related to: Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer

  1. You have free access to this content
    Guidelines for the management of thyroid cancer

    Clinical Endocrinology

    Volume 81, Issue s1, July 2014, Pages: 1–122, Dr Petros Perros, Dr Kristien Boelaert, Dr Steve Colley, Dr Carol Evans, Dr Rhodri M Evans, Dr Georgina Gerrard BA, Dr Jackie Gilbert, Dr Barney Harrison, Dr Sarah J Johnson, Dr Thomas E Giles, Dr Laura Moss, Professor Val Lewington, Dr Kate Newbold, Mrs Judith Taylor, Professor Rajesh V Thakker, Professor John Watkinson and Professor Graham R. Williams

    Version of Record online : 3 JUL 2014, DOI: 10.1111/cen.12515

  2. Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials

    Clinical Endocrinology

    Volume 83, Issue 5, November 2015, Pages: 702–710, Yen-Ying Lee, Ka-Wai Tam, You-Meei Lin, Wuan-Jin Leu, Jui-Chia Chang, Chi-Lien Hsiao, Meng-Ting Hsu and An-Tsz Hsieh

    Version of Record online : 29 DEC 2014, DOI: 10.1111/cen.12654

  3. Beneficial effects of adequate iodine supply on characteristics of thyroid autonomy

    Clinical Endocrinology

    Volume 79, Issue 6, December 2013, Pages: 867–873, Simona Gaberšček, Vid Bajuk, Katja Zaletel, Edvard Pirnat and Sergej Hojker

    Version of Record online : 23 APR 2013, DOI: 10.1111/cen.12215

  4. Intermediate-risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long-term outcome study

    Clinical Endocrinology

    Volume 84, Issue 3, March 2016, Pages: 408–416, Sanjana Ballal, Ramya Soundararajan, Aayushi Garg, Saurav Chopra and Chandrasekhar Bal

    Version of Record online : 7 MAY 2015, DOI: 10.1111/cen.12779

  5. Can radioiodine be administered effectively and safely to a patient with severe chronic kidney disease?

    Clinical Endocrinology

    Volume 81, Issue 2, August 2014, Pages: 169–174, Marek Saracyn, Marek Bilski, Grzegorz Kamiński and Stanisław Niemczyk

    Version of Record online : 22 MAY 2014, DOI: 10.1111/cen.12480

  6. An easy schedule for postsurgical radioiodine administration in newly diagnosed differentiated thyroid carcinoma patients

    Clinical Endocrinology

    Volume 78, Issue 1, January 2013, Pages: 145–151, Gelsy A. Lupoli, Maria R. Poggiano, Annalisa Panico, Luciana Granieri, Roberta Lupoli, Marianna Cacciapuoti and Giovanni Lupoli

    Version of Record online : 11 DEC 2012, DOI: 10.1111/cen.12004

  7. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease

    Clinical Endocrinology

    Volume 80, Issue 2, February 2014, Pages: 296–300, Sarah Côté-Bigras, Audrey Dionne, Patrick Asselin-Mullen, Coralie Leblicq and Diane Rottembourg

    Version of Record online : 27 JUN 2013, DOI: 10.1111/cen.12257

  8. You have full text access to this OnlineOpen article
    Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1031–1038, Chandrasekhar Bal, Sanjana Ballal, Ramya Soundararajan, Saurav Chopra and Aayushi Garg

    Version of Record online : 9 MAR 2015, DOI: 10.1002/cam4.443

  9. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma

    Head & Neck

    Volume 32, Issue 6, June 2010, Pages: 689–698, Alon Vaisman, Steven Orlov, Jonathan Yip, Cindy Hu, Terence Lim, Mark Dowar, Jeremy L. Freeman and Paul G. Walfish

    Version of Record online : 24 FEB 2010, DOI: 10.1002/hed.21371

  10. US not bright but right method of thyroid volume estimation even in large and substernal extended goitres. Comparison of US and three methods of CT thyroid evaluation – prospective study

    Clinical Endocrinology

    Volume 83, Issue 3, September 2015, Pages: 412–419, Sonia Kaniuka-Jakubowska, Maciej Piskunowicz, Adam Zapaśnik, Anna Lewczuk, Aneta Kaniuka, Krystyna Mizan-Gross, Mariusz Kaszubowski, Piotr Lass and Krzysztof Sworczak

    Version of Record online : 27 NOV 2014, DOI: 10.1111/cen.12629

  11. No significant difference in the prognostic value of the 5th and 7th editions of AJCC staging for differentiated thyroid cancer

    Clinical Endocrinology

    Volume 80, Issue 6, June 2014, Pages: 911–917, Alexis Vrachimis, Joachim Gerss, Maren Stoyke, Christian Wittekind, Tobias Maier, Christian Wenning, Kambiz Rahbar, Otmar Schober and Burkhard Riemann

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cen.12405

  12. Graves' disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?

    Clinical Endocrinology

    Volume 80, Issue 5, May 2014, Pages: 629–632, Anthony P. Weetman

    Version of Record online : 9 APR 2014, DOI: 10.1111/cen.12427

  13. Is lithium an effective adjunct therapy for radioiodine therapy for hyperthyroidism?

    Clinical Endocrinology

    Volume 77, Issue 4, October 2012, Pages: 513–514, Mark Vanderpump

    Version of Record online : 11 SEP 2012, DOI: 10.1111/j.1365-2265.2012.04425.x

  14. A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin

    Clinical Endocrinology

    Volume 86, Issue 1, January 2017, Pages: 128–133, Naris Nilubol, Roxanne Merkel, Lily Yang, Dhaval Patel, James C. Reynolds, Samira M. Sadowski, Vladimir Neychev and Electron Kebebew

    Version of Record online : 8 SEP 2016, DOI: 10.1111/cen.13154

  15. You have free access to this content
    Radioiodine therapy versus antithyroid medications for Graves' disease

    Intervention Review

    The Cochrane Library

    Chao Ma, Jiawei Xie, Hui Wang, Jinsong Li and Suyun Chen

    Published Online : 18 FEB 2016, DOI: 10.1002/14651858.CD010094.pub2

  16. Effects of radioiodine treatment for differentiated thyroid cancer on testis function

    Clinical Endocrinology

    Volume 82, Issue 2, February 2015, Pages: 295–299, Domenico Canale, Claudia Ceccarelli, Carolina Caglieresi, Agnese Moscatelli, Silvia Gavioli, Pierina Santini, Rossella Elisei and Paolo Vitti

    Version of Record online : 20 AUG 2014, DOI: 10.1111/cen.12514

  17. Thyroglobulin as early prognostic marker to predict remission at 18–24 months in differentiated thyroid carcinoma

    Clinical Endocrinology

    Volume 80, Issue 2, February 2014, Pages: 301–306, Cintia González, Anna Aulinas, Cristina Colom, Diana Tundidor, Lilian Mendoza, Rosa Corcoy, Eugenia Mato, Valeria Alcántara, Eulalia Urgell Rull and Alberto de Leiva

    Version of Record online : 31 JUL 2013, DOI: 10.1111/cen.12282

  18. You have free access to this content
    The Thyroid – too much and too little across the ages. The consequences of subclinical thyroid dysfunction

    Clinical Endocrinology

    Volume 78, Issue 1, January 2013, Pages: 1–8, Jayne A. Franklyn

    Version of Record online : 11 DEC 2012, DOI: 10.1111/cen.12011

  19. You have free access to this content
    Low iodine diet in differentiated thyroid cancer: a review

    Clinical Endocrinology

    Volume 84, Issue 1, January 2016, Pages: 3–12, Josephine H. Li, Zhiheng H. He, Vivek Bansal and James V. Hennessey

    Version of Record online : 29 JUL 2015, DOI: 10.1111/cen.12846

  20. Clinical applications of SPECT/CT after first I-131 ablation in patients with differentiated thyroid cancer

    Clinical Endocrinology

    Volume 81, Issue 3, September 2014, Pages: 445–451, Shin Young Jeong, Sang-Woo Lee, Hae Won Kim, Bong-Il Song, Byeong-Cheol Ahn and Jaetae Lee

    Version of Record online : 5 MAY 2014, DOI: 10.1111/cen.12460